Thrive Earlier Detection Corp.

Quest Diagnostics Incorporated is buying cancer-detection company Haystack Oncology for $300m in cash with plans to launch their liquid biopsy test in 2024, the companies announced on 27 April. Balti

In Vivo's editors, along with experts from the Informa Pharma Intelligence team, have selected our top five picks for the most significant M&A, alliance and financing deals of 2021. Vote now in the p

The top themes and talking points that will influence medtech decision-making and operating conditions in 2022 are listed below. A Consolidating Industry Where Major M&A Continues Apace Although there

In Vivo has collected the top 10 themes and talking points that will influence medtech decision-making and operating conditions in 2022. A Consolidating Industry Where Major M&A Continues Apace Altho